Atorvastatin Calcium
Product Images NDC 42571-173

8 FDA label images from Micro Labs Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 42571-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1 (Atorvastatinfig1)

Fig 1 (Atorvastatinfig1)
A line graph showing cumulative incidence (%) over time (years) comparing Atorvastatin and Placebo groups. The Atorvastatin group is represented by a solid line, and the Placebo group by a dashed line, with the Placebo group showing higher cumulative incidence. The graph includes hazard ratio (HR = 0.64) and p-value (p=0.0005) at the bottom right.*
FDA Label Image

Fig 2 (Atorvastatinfig2)

Fig 2 (Atorvastatinfig2)
A line graph showing cumulative hazard percentage over time in years, comparing placebo and atorvastatin treatment groups. The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentage. The atorvastatin group has a lower cumulative hazard compared to placebo. Hazard ratio and p-value are noted on the graph.*
FDA Label Image

Fig 3 (Atorvastatinfig3)

Fig 3 (Atorvastatinfig3)
A Kaplan-Meier survival curve graph comparing Atorvastatin 10 mg and 80 mg doses. The x-axis shows time to first major cardiovascular endpoint in years (0 to 5), and the y-axis indicates the percentage of subjects experiencing the event. The graph includes hazard ratio (HR 0.78) and P-value (0.0002) data.*
FDA Label Image

Structure (Atorvastatinstrc)

Structure (Atorvastatinstrc)
Chemical structure of atorvastatin calcium showing the molecular arrangement including phenyl, fluorophenyl groups, hydroxyl groups, and calcium ions with hydration.*
FDA Label Image

Atorvaststionlabl1

Atorvaststionlabl1
Label for Atorvastatin Calcium Tablets 10 mg by Micro Labs Limited. The label includes the product name, dosage strength, and quantity (90 tablets). It states Rx only and provides manufacturer information for Micro Labs Limited, India, and Micro Labs USA, Inc. The label also contains storage instructions and a barcode, with a focus on the 10 mg dose of atorvastatin calcium tablets.*
FDA Label Image

Atorvaststionlabl2

Atorvaststionlabl2
Label for Atorvastatin Calcium Tablets 20 mg by Micro Labs Limited, showing a bottle or carton label with dosage strength, NDC 42571-173-90, package size of 90 tablets, storage instructions, and manufacturer information including Micro Labs Limited, Goa, India, and Micro Labs USA, Inc., New Jersey. The label includes barcodes and a trademark logo for Micro Labs.*
FDA Label Image

Atorvaststionlabl3

Atorvaststionlabl3
Label for Atorvastatin Calcium Tablets 40 mg film-coated tablets, manufactured by Micro Labs Limited and labeled for Micro Labs USA, Inc. The package contains 90 tablets. Storage instructions specify 20°C to 25°C. The label includes the NDC 42571-174-90 and manufacturer addresses in India and the USA.*
FDA Label Image

Atorvaststionlabl4

Atorvaststionlabl4
Label of Atorvastatin Calcium Tablets 80 mg by Micro Labs Limited. The label indicates each film-coated tablet contains 80 mg of Atorvastatin (86.754 mg Atorvastatin Calcium USP equivalent). The package contains 90 tablets and is labeled Rx only. The label includes storage instructions, manufacturer and distributor information, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.